SI-BONE Statistics
Total Valuation
SI-BONE has a market cap or net worth of $665.68 million. The enterprise value is $558.18 million.
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SI-BONE has 44.35 million shares outstanding. The number of shares has increased by 3.70% in one year.
| Current Share Class | 44.35M |
| Shares Outstanding | 44.35M |
| Shares Change (YoY) | +3.70% |
| Shares Change (QoQ) | +1.04% |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 107.28% |
| Float | 42.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.20 |
| Forward PS | 2.74 |
| PB Ratio | 3.68 |
| P/TBV Ratio | 3.69 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 352.14 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.71 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.99, with a Debt / Equity ratio of 0.24.
| Current Ratio | 9.99 |
| Quick Ratio | 8.20 |
| Debt / Equity | 0.24 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.80 |
Financial Efficiency
Return on equity (ROE) is -9.65% and return on invested capital (ROIC) is -5.85%.
| Return on Equity (ROE) | -9.65% |
| Return on Assets (ROA) | -5.30% |
| Return on Invested Capital (ROIC) | -5.85% |
| Return on Capital Employed (ROCE) | -9.01% |
| Weighted Average Cost of Capital (WACC) | 7.89% |
| Revenue Per Employee | $548,465 |
| Profits Per Employee | -$44,404 |
| Employee Count | 376 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 1.28 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.71% in the last 52 weeks. The beta is 0.70, so SI-BONE's price volatility has been lower than the market average.
| Beta (5Y) | 0.70 |
| 52-Week Price Change | -18.71% |
| 50-Day Moving Average | 13.65 |
| 200-Day Moving Average | 15.74 |
| Relative Strength Index (RSI) | 60.62 |
| Average Volume (20 Days) | 805,436 |
Short Selling Information
The latest short interest is 5.70 million, so 12.86% of the outstanding shares have been sold short.
| Short Interest | 5.70M |
| Short Previous Month | 4.54M |
| Short % of Shares Out | 12.86% |
| Short % of Float | 13.32% |
| Short Ratio (days to cover) | 7.01 |
Income Statement
In the last 12 months, SI-BONE had revenue of $206.22 million and -$16.70 million in losses. Loss per share was -$0.39.
| Revenue | 206.22M |
| Gross Profit | 164.13M |
| Operating Income | -19.94M |
| Pretax Income | -16.70M |
| Net Income | -16.70M |
| EBITDA | -13.83M |
| EBIT | -19.94M |
| Loss Per Share | -$0.39 |
Full Income StatementBalance Sheet
The company has $144.68 million in cash and $42.95 million in debt, with a net cash position of $101.74 million or $2.29 per share.
| Cash & Cash Equivalents | 144.68M |
| Total Debt | 42.95M |
| Net Cash | 101.74M |
| Net Cash Per Share | $2.29 |
| Equity (Book Value) | 178.94M |
| Book Value Per Share | 4.05 |
| Working Capital | 193.23M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.87 million and capital expenditures -$7.42 million, giving a free cash flow of -$5.55 million.
| Operating Cash Flow | 1.87M |
| Capital Expenditures | -7.42M |
| Depreciation & Amortization | 6.11M |
| Net Borrowing | n/a |
| Free Cash Flow | -5.55M |
| FCF Per Share | -$0.13 |
Full Cash Flow StatementMargins
Gross margin is 79.59%, with operating and profit margins of -9.67% and -8.10%.
| Gross Margin | 79.59% |
| Operating Margin | -9.67% |
| Pretax Margin | -8.10% |
| Profit Margin | -8.10% |
| EBITDA Margin | -6.71% |
| EBIT Margin | -9.67% |
| FCF Margin | n/a |
Dividends & Yields
SI-BONE does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.70% |
| Shareholder Yield | -3.70% |
| Earnings Yield | -2.53% |
| FCF Yield | -0.84% |
Analyst Forecast
The average price target for SI-BONE is $24.13, which is 60.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $24.13 |
| Price Target Difference | 60.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (3Y) | 14.84% |
| EPS Growth Forecast (3Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SI-BONE has an Altman Z-Score of 5.6 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.6 |
| Piotroski F-Score | 5 |
